Deep-tech companies often face two financing problems at once. Technical work may still be too uncertain for ordinary investors, while grants alone may not provide the capital, ownership structure, or commercial discipline needed for manufacturing, market entry, and scale-up. The European Innovation Council Accelerator addresses that gap with blended finance: a grant component can sit beside an investment component in the same support pathway.
The phrase “grant plus equity” sounds simple, but it should not be read as one undivided award. The European Commission manages the grant decision and agreement. The EIC Fund considers the investment after due diligence and negotiates its instrument and terms. A company can therefore be selected for blended finance without every investment detail being settled on selection day.
Why one financing tool may not be enough#
A conventional research grant pays eligible project costs against a defined work plan. It can fund technical validation, testing, demonstration, regulatory preparation, and other innovation activities without taking an ownership stake. That is valuable when scientific and engineering uncertainty remains high.
Scale-up creates a different cash need. A company may have to expand production, recruit a commercial team, build distribution, or finance a longer route to revenue. Those uses do not always fit a grant budget. Equity capital can absorb risk over a longer horizon, but it gives the investor an ownership interest and usually comes with negotiated governance and information rights.
Blended finance joins these tools without pretending they are interchangeable. The grant can reduce technical risk. The investment can finance company growth and help bring in other investors. The intended sequence is visible in the EIC process: grant preparation can begin while the EIC Fund conducts investment due diligence and explores the financing structure.
This sits later in the path described in the map from biological idea to clinical use. It also complements early health technology assessment, which asks whether the proposed innovation could create value before its evidence plan and design become fixed.
What the 2026 EIC Accelerator offers#
The current EIC Accelerator page describes three main forms of support: grant only, investment only, and blended finance. The programme focuses on startups and small and medium-sized companies with high-risk, market-creating innovations. Certain individuals planning to establish an eligible company and some small mid-caps can apply under specified conditions.
For 2026, the grant component is a lump-sum contribution below €2.5 million. The applicant guide states that it can cover up to 70 percent of eligible costs, with the supported innovation activities generally completed within 24 months. Those activities are aimed at technology readiness levels 6 to 8.
The standard investment component is listed at €1 million to €10 million. It may use direct equity or quasi-equity, such as a convertible instrument. Separate STEP Scale Up support can involve larger amounts, so its figures should not be copied into an ordinary Accelerator application.
These numbers are programme rules, not a valuation promise. A request still needs to match the financing gap, the work plan, the company’s capitalization, and the evidence supplied. The work programme and call documents control if a summary page and a specific call ever appear to differ.
Selection and investment are separate decisions#
The application process begins with a short proposal. A successful short proposal allows the applicant to prepare a full proposal for a batching date. The full proposal is assessed by technical and evaluation experts, and the strongest qualifying applications may be invited to a jury interview.
A jury recommendation is a major threshold, but it does not complete the investment. For grant-only support, the next step is the grant agreement. For blended finance, information also moves to the EIC Fund, where financial, legal, compliance, and commercial due diligence begins. The fund manager then considers the structure, potential co-investors, terms, and approval.
The EIC guidance says that if a company is not ready for investment, it may begin with the grant component and return to the investment question at defined milestones. That sequencing is useful, but it is not automatic capital. Milestones can affect timing, tranches, and whether the investment proceeds.
The distinction protects both sides. Public grant money remains tied to the approved innovation action. Investment capital is governed as an investment, with attention to valuation, ownership, investor rights, and exit. Treating the two as a single cheque would hide those different accountabilities.
What equity changes for the company#
Grant funding is non-dilutive, but it is not unrestricted. The recipient must deliver the agreed action, respect eligible-cost and reporting rules, and meet the terms of the grant agreement.
Equity is dilutive. Issuing shares changes the percentages owned by founders and existing investors. Quasi-equity may delay that change, but a convertible can still create dilution later. The relevant question is not merely how much capital arrives. It is what security is issued, at which valuation, with which rights, and under which future scenarios.
Founders should examine voting rights, board or observer rights, information rights, reserved matters, anti-dilution terms, liquidation preferences, follow-on participation, and exit expectations. Not every instrument contains every term. That is precisely why the investment must be modeled from the actual term sheet rather than from a programme summary.
The EIC Fund describes itself as patient capital and seeks to attract private co-investment. Crowding in other capital can expand a financing round, but it adds coordination. Different investors may have their own diligence, mandate, timetable, and conditions. A company should plan for the cash runway needed while these processes unfold.
How to decide whether blended finance fits#
Start with a financing map, not the maximum available amount. List the technical milestones, commercial milestones, cash required for each, and the evidence that would reduce the next uncertainty. Then separate uses that fit an innovation-action grant from uses that require company capital.
Three tests sharpen the choice:
- Technical additionality: Is there a defined innovation activity whose risk prevents ordinary financing and whose result can be measured?
- Investment need: Does the company need capital for deployment or scale-up beyond the grant action, and can it explain why private funding alone is not yet sufficient?
- Ownership readiness: Do founders and existing investors understand the dilution, governance, diligence, and co-investment consequences?
A coherent application connects these pieces. The technical plan should support the commercial case. The financing request should follow the cash model. The claimed market opportunity should be consistent with regulatory, reimbursement, procurement, production, and adoption constraints.
Read the exact call, not a remembered headline#
EIC rules evolve. Amounts, batching dates, templates, eligibility, evaluation procedures, and investment ranges can change between work programmes. Older news releases may accurately describe the year in which they were issued but no longer describe the current call.
Record the work-programme year and access date beside every planning assumption. Recheck the official call before submission and again before accepting terms. Use professional legal, tax, accounting, and investment advice for the company’s actual financing documents.
The practical point is straightforward: grant plus equity is a financing architecture, not a bonus layered onto a grant. Its value comes from matching technical risk with project support and scale-up risk with investment capital while keeping the two decisions visible.
References#
- European Commission, EIC Accelerator programme page
- European Innovation Council Work Programme 2026
- European Commission, EIC Accelerator Guide for Applicants 2026
- European Commission, EIC Fund Investment Guidelines and Approach
- European Commission, EIC Accelerator frequently asked questions
Programme rules and company circumstances change, so verify the applicable call and obtain qualified advice.*
Questions and answers
What does grant plus equity mean in European deep-tech funding?
In EIC Accelerator blended finance, a grant supports defined innovation activities while a separate investment component provides equity or quasi-equity capital for deployment and scale-up.
Does an EIC Accelerator award guarantee the investment?
No. The grant agreement and the investment decision are separate, and the investment component remains subject to due diligence, structuring, and final approval.
Does equity have to be repaid like a loan?
Ordinary equity is ownership rather than debt, while quasi-equity can use instruments such as convertibles. The exact rights, conversion terms, and exit path depend on the negotiated instrument.
Is the EIC Accelerator the same as a research grant?
No. It is aimed mainly at startups and small and medium-sized companies developing market-creating innovations, with support spanning late technical development and scale-up.
Which rules should an applicant rely on?
Use the work programme, call documents, application forms, and investment guidance that apply to the specific year and call because amounts, eligibility, and process details can change.